NEUROGEN CORP
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventDec 24, 2009
- Delisting / listing-standard noticeDec 17, 2009
- Entered a material agreementDec 17, 2009
- Director / officer changeNov 18, 2009
- Entered a material agreement · Results of operationsNov 6, 2009
- Entered a material agreement · Regulation FD disclosureAug 24, 2009
- Results of operationsAug 14, 2009
- Results of operations · Other material eventMay 12, 2009
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12G/AFORM 15-13G/AMar 15, 2010
- SC 13G/AAMENDMENT NO. 2Feb 16, 2010
- SC 13G/AAMENDMENT NO. 3Feb 16, 2010
- SC 13G/ANEUROGEN 13GA2Feb 8, 2010
- EFFECTJan 12, 2010
- EFFECTJan 12, 2010
- EFFECTJan 12, 2010
- EFFECTJan 12, 2010
- EFFECTJan 12, 2010
- POS AMPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-3Jan 12, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Jan 12, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Jan 12, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Jan 12, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Jan 12, 2010
- S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Jan 12, 2010
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.